γ-羟丁酸中毒:临床诊断与实验室检查结果的比较
本研究为前瞻性观察性研究,纳入87例≥16岁因临床诊断γ-羟丁酸中毒入院的患者,入院时采血用超高效液相色谱-串联质谱法检测。60例(69.0%)血中检出γ-羟丁酸;阳性患者入院时格拉斯哥昏迷评分中位数6分(IQR 3-10),53.3%阳性患者评分为3分,阳性者评分显著更低(P<0.001)且与γ-羟丁酸浓度呈负相关。60例阳性患者中28例(46.7%)需ICU治疗,3例(5.0%)需气管插管;58例(96.7%)阳性患者同时检出其他药物,最常见为苯丙胺类、可卡因和苯二氮䓬类。作者认为其他精神活性药物频繁共用使临床诊断困难,临床医生可能过度诊断γ-羟丁酸中毒。
要点
- 87例临床诊断γ-羟丁酸中毒患者中仅60例(69.0%)血样检出γ-羟丁酸,提示临床可能过度诊断。
- γ-羟丁酸阳性患者入院格拉斯哥昏迷评分中位数6分(IQR 3-10),53.3%阳性患者评分为3分。
- 阳性患者格拉斯哥昏迷评分显著低于阴性患者(P<0.001),且与γ-羟丁酸血浓度呈负相关。
- 60例阳性患者中28例(46.7%)需ICU治疗,3例(5.0%)需气管插管。
- 58/60例(96.7%)阳性患者同时检出其他药物,最常见为苯丙胺类、可卡因和苯二氮䓬类。
适用人群与场景
- ≥16岁因临床诊断γ-羟丁酸中毒入院治疗的患者。
- 诊断由接诊医生根据临床信息和/或患者和/或陪同人员提供的信息确立。
诊断标准与关键阈值
- 临床诊断γ-羟丁酸中毒由接诊医生根据临床信息和/或患者和/或陪同人员提供的信息确立。
- 入院时采血,采用超高效液相色谱-串联质谱法检测血中γ-羟丁酸。
红旗征与不能漏的情况
- γ-羟丁酸中毒临床表现异质,意识水平常不稳定,可在躁动与昏迷之间波动。
- γ-羟丁酸阳性患者入院格拉斯哥昏迷评分中位数6分(IQR 3-10),53.3%阳性患者评分为3分。
- 60例阳性患者中28例(46.7%)需ICU治疗,3例(5.0%)需气管插管。
研究设计与关键结果
- 前瞻性观察性研究纳入87例患者,中位年龄35岁(IQR 30-42岁),58.6%(51/87)为男性。
- 血样中检出γ-羟丁酸者60例(69.0%)。
- 全部患者入院时格拉斯哥昏迷评分中位数6分(IQR 3-10),γ-羟丁酸阳性患者中53.3%评分为3分。
- γ-羟丁酸阳性患者格拉斯哥昏迷评分显著更低(P<0.001),且与γ-羟丁酸浓度呈负相关。
- 60例阳性患者中28例(46.7%)需ICU治疗,3例(5.0%)需气管插管。
- 60例阳性患者中58例(96.7%)同时检出其他药物,最常见为苯丙胺类、可可卡因和苯二氮䓬类。
证据类型、等级与局限
- 证据类型:前瞻性观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 临床怀疑γ-羟丁酸中毒的患者中仅约三分之二血样检出γ-羟丁酸,作者认为临床医生可能过度诊断γ-羟丁酸中毒。
- 其他精神活性药物的频繁共用使γ-羟丁酸中毒的临床诊断具有挑战性,γ-羟丁酸检测阴性患者中常见其他中枢神经系统抑制剂中毒。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Patients poisoned with gamma-hydroxybutyrate may need urgent medical treatment. The clinical manifestations are heterogeneous, and the level of consciousness is often unstable, with fluctuations between agitation and coma. We aimed to investigate the accuracy of the clinical diagnosis of gamma-hydroxybutyrate poisoning compared to laboratory findings in blood samples.
METHODS: We did a prospective observational study, including patients ≥16 years of age admitted to hospital with a clinical diagnosis of gamma-hydroxybutyrate poisoning. The diagnosis was established by the doctor treating the patient based on the clinical information and/or information from the patient and/or the patient's companions. Blood samples were taken at admission and analyzed using ultra high-performance liquid chromatography-tandem mass spectrometry.
RESULTS: There were 87 patients with a median age of 35 years (IQR: 30-42 years), and 58.6% (51/87) were male. Gamma-hydroxybutyrate was found in blood samples taken from 60 (69.0%) patients. The median Glasgow Coma Scale of all patients on arrival at hospital was 6 (IQR: 3-10), and 53.3% of the patients who tested positive for gamma-hydroxybutyrate presented with a Glasgow Coma Scale of 3. The Glasgow Coma Scale was significantly lower (P <0.001) among patients who tested positive for gamma-hydroxybutyrate, and was inversely correlated with gamma-hydroxybutyrate concentrations. Among the 60 patients testing positive for gamma-hydroxybutyrate, 28 (46.7%) needed treatment in an intensive care unit, and three (5.0%) required endotracheal intubation. In 58 (96.7%) of the 60 patients who tested positive for gamma-hydroxybutyrate, other drugs were also found, most frequently amfetamines, cocaine, and benzodiazepines.
DISCUSSION: The frequent co-consumption of other psychoactive drugs makes the clinical diagnosis of gamma-hydroxybutyrate challenging, and poisoning with other central nervous system depressants was frequently observed among those patients testing negative for the gamma-hydroxybutyrate.
CONCLUSIONS: In only two out of three patients with clinically suspected gamma-hydroxybutyrate poisoning was gamma-hydroxybutyrate found in a blood sample, indicating that clinicians might overdiagnose gamma-hydroxybutyrate poisoning.
参考来源
- Skjelland D, Jørgenrud BM, Gundersen K, et al. Gamma-hydroxybutyrate poisoning: clinical diagnosis versus laboratory findings. Clin Toxicol (Phila). 2025. PMID: 40272047. doi:10.1080/15563650.2025.2463700
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。